A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis
ConclusionsDespite the relatively frequent presence of liver autoantibodies, tested either by IF or molecular assays, overt AILD is rather infrequent discouraging autoantibody screening strategies of MS patients in the absence of clinical suspicion.
Source: Autoimmunity Highlights - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Hepatitis | Liver | Liver Disease | Multiple Sclerosis | Pancreas | Urology & Nephrology